Cargando…
Paromomycin: A potential dual targeted drug effectively inhibits both spike (S1) and main protease of COVID-19
OBJECTIVES: With the increasing number of people suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a dire need to look for effective remedies against this pandemic. Drug repurposing seems to be the solution for the cu...
Autores principales: | Tariq, Asma, Mateen, Rana Muhammad, Afzal, Muhammad Sohail, Saleem, Mahjabeen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306207/ https://www.ncbi.nlm.nih.gov/pubmed/32579907 http://dx.doi.org/10.1016/j.ijid.2020.06.063 |
Ejemplares similares
-
Dual inhibition of COVID-19 spike glycoprotein and main protease 3CLpro by Withanone from Withania somnifera
por: Patil, Vishal Shivalingappa, et al.
Publicado: (2021) -
Crime scene investigation in Pakistan: A perspective
por: Mateen, Rana Muhammad, et al.
Publicado: (2019) -
Leishmanicidal Activity of Films Containing Paromomycin and Gentamicin Sulfate both In Vitro and In Vivo
por: Tolouei, S, et al.
Publicado: (2011) -
Atomic resolution snapshot of Leishmania ribosome inhibition by the aminoglycoside paromomycin
por: Shalev-Benami, Moran, et al.
Publicado: (2017) -
Paromomycin Affects Translation and Vesicle-Mediated Trafficking as Revealed by Proteomics of Paromomycin –Susceptible –Resistant Leishmania donovani
por: Chawla, Bhavna, et al.
Publicado: (2011)